 Atea Pharmaceuticals, Inc. NASDAQ:AVIR Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Jean-Pierre Sommadossi - Founder CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO EVP, Legal John Vavricka - Chief Commercial Officer Jonae Barnes - SVP, IR Corporate Communications Conference Call Participants Hannah Colgan - JPMorgan Umer Raffat - Evercore Nik Gasic - SVB Securities Jonathan Miller - Evercore Operator Good morning, and welcome to the Atea Pharmaceuticals First Quarter 2022 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode to prevent any background noise. 